Nevada Topping $30M in Tax Revenue from Cannabis Sales | CashCropToday
0 Shares 188 Views

Nevada Topping $30M in Tax Revenue from Cannabis Sales

March 5, 2018
188 Views

Nevada’s cannabis industry is still in its infancy but in just six months the cannabis market has already raked in more than $30 million in tax revenue for the state. During this time, retailers in the state have sold more than $195 million in cannabis.

The state charges a 15% tax on wholesale cannabis and a 10% tax on retail sales and has seen its cannabis sales soar past Colorado’s during the first months of its legal market. Cannabis analytics firm New Frontier projects Nevada’s state-legal cannabis market to be worth $622 million by 2020. With nearly 85% of Nevada being federally owned, much of the market’s success can be attributed to the tourist-friendly city of Las Vegas with its culture of fun and excess.

While there has been some political wrangling over how the money gets distributed, the state is sending a good chunk of it towards education. Other cannabis-legal states have done the same. In Colorado, wholesale pot taxes are set aside for a public-school fund, in addition to paying for regulatory oversight, youth drug prevention, and substance abuse treatment. Just the thought of that much tax revenue has caused some cash-strapped states to consider legalizing cannabis. But, according to Andrew Freedman, Colorado’s first marijuana czar, potential tax revenue shouldn’t factor into the legalization discussion: saying, “At the end of the day, the debate shouldn’t be about tax revenue. ‘Should we lock up fewer people for marijuana?’ vs. ‘Is this going to create more of a burden on public safety?’—that’s where the debate should be.”

You may be interested

Global Hemp Group Announces Harvest Update on their CBD Hemp Farm in Scio Oregon
Market Watch
270 views
Market Watch
270 views

Global Hemp Group Announces Harvest Update on their CBD Hemp Farm in Scio Oregon

Editor - November 27, 2018

Vancouver, BC -- (November 27, 2018) -- GLOBAL HEMP GROUP INC. (“GHG” or the “Company”) (CSE: GHG / OTC: GBHPF / FRANKFURT: GHG) and its joint venture…

Wayland Group Enters UK Cannabis Market with Theros Pharma Acquisition
Global
194 views
Global
194 views

Wayland Group Enters UK Cannabis Market with Theros Pharma Acquisition

Editor - November 26, 2018

Wayland Group (CSE:WAYL) (OTCQB:MRRCF) has announced this morning that their company has entered into an agreement to acquire 51% of UK company Theros Pharma Ltd. The Wayland Group…

GW Pharma’s CBD Pharmaceutical, Epidiolex, Shows Results in Lowering Seizures in Clinical Trials
Manufacturing
190 views
Manufacturing
190 views

GW Pharma’s CBD Pharmaceutical, Epidiolex, Shows Results in Lowering Seizures in Clinical Trials

Editor - November 26, 2018

GW Pharmaceuticals (Nasdaq: GWPH) has announced this morning that their company has completed a double-blind, placebo-controlled Phase 3 clinical trial for its Cannabidiol (CBD) derived product EPIDIOLEX®.…

Leave a Comment

Your email address will not be published.

Most from this category

%d bloggers like this: